One of Pfizer’s antibiotics suppliers in China, NCPC, discharges pharmaceutical waste into the environment. Generic drug company McKesson contracts with an Indian company, Aurobindo, which in turn gets drug supplies from four polluting Chinese factories. And Teva, based in Israel, deals with three Chinese companies that “have been in the Chinese media spotlight for various offenses including improper waste management and the release of noxious chemicals.”
read more